Joint Formulary & PAD

Orphenadrine hydrochloride - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Orphenadrine hydrochloride
Indication :
Parkinson's disease
Group Name :
Keywords :
anticholinergics, motor fluctuations, dyskinesia, PD
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Orphenadrine hydrochloride is used to treat.

  • No records returned.

Committee Recommendations (1)

NICE does not recommend the use of anticholinergics in Parkinson's disease for patients who have developed dyskinesia and / or motor fluctuations.